Please login to the form below

Not currently logged in
Email:
Password:

Pfizer launches chronic pain forum

Twitter style comments are used to help patients describe their conditions

Pain-exchange-Pfizer

Pfizer has launched an online forum called The Pain Exchange, which has been designed to encourage conversations between people suffering from chronic pain.

Similar to Twitter, the descriptions should be 140 characters or less and can be rated on a pain severity scale. In addition, users are asked questions, such as age, gender, medical diagnosis etc, which will be compiled to help create a user generated database of chronic pain experiences.

One of the aims of the project is to enable people to better communicate their symptoms, by learning how others describe their pain, which should subsequently help GPs to diagnose and treat the condition during consultations.

"GPs rely on patients to describe their chronic pain so that the correct diagnosis can be made, but the subjective nature of pain and the patient challenges in accurately describing their symptoms mean that GPs find it hard to define, measure and accurately diagnose chronic pain", said Dr Roger Henderson, GP and Pain Exchange supporter.

"To add to the pressure on GPs, there is only one pain specialist per 32,000 sufferers in the UK to support the work of primary care. This increased pressure demonstrates the need for GPs to understand chronic pain and how to effectively and efficiently manage and treat patients at the point of consultation", he added.

The launch of the website is part of the Pfizer-funded European health awareness campaign Can you feel my pain, which includes a Facebook page, a Twitter feed and a Flickr album.

To mark the launch of the site an event was staged on London's South Bank called The Pain Exchange Buzz Wire Challenge. Set up by Red Door Communications, the event saw participants attempting to navigate a large buzz wire in the shape of the word pain.

29th January 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...